How do you switch a patient from Depo-Provera (medroxyprogesterone acetate) to Seasonale (levonorgestrel/ethinyl estradiol) birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Depo-Provera to Seasonale

Start Seasonale immediately when the next Depo-Provera injection is due (at 13 weeks), and use backup contraception (condoms or abstinence) for 7 days after starting the combined oral contraceptive. 1

Timing of the Switch

  • Initiate Seasonale at the time the next Depo injection would be due (13 weeks from the last injection), as this represents the standard reinjection interval for DMPA. 1

  • You may start Seasonale up to 2 weeks after the scheduled injection date (up to 15 weeks from the last injection) without additional pregnancy risk during the transition, as DMPA maintains contraceptive efficacy during this window. 1

  • If starting Seasonale more than 15 weeks after the last Depo injection, verify the patient is not pregnant before initiating the combined oral contraceptive. 1

Backup Contraception Requirements

  • The patient must use backup contraception (condoms or abstinence) for 7 days after starting Seasonale, regardless of when in the cycle she begins the pill. 1

  • This 7-day backup period is necessary because combined oral contraceptives require time to suppress ovulation when initiated outside the first 5 days of menses. 1

Key Clinical Considerations

  • Counsel the patient about expected menstrual changes during the transition. Most patients on Depo-Provera experience amenorrhea (57% by 12 months of use), and switching to Seasonale will eventually restore a more predictable bleeding pattern, though withdrawal bleeding will only occur every 3 months with this extended-cycle formulation. 2

  • Address weight concerns proactively. Weight gain is common with DMPA (reported in 18% of discontinuers), and patients may be switching specifically due to this side effect. 3 Reassure patients that weight stabilization typically occurs after stopping Depo-Provera. 4

  • Inform patients about return to fertility. While DMPA can delay return to fertility for 9-18 months after discontinuation, switching to Seasonale provides immediate reversibility once the combined oral contraceptive is stopped. 5, 6, 4

Common Pitfalls to Avoid

  • Do not wait for a menstrual period to return before starting Seasonale. Many Depo-Provera users are amenorrheic, and waiting for menses is unnecessary and increases pregnancy risk. 1

  • Do not assume contraceptive coverage is continuous without backup. Even though DMPA provides coverage up to 15 weeks, the 7-day backup period is still required when initiating any combined oral contraceptive. 1

  • Do not forget to verify the patient has no contraindications to estrogen-containing contraceptives (such as history of thromboembolism, migraine with aura, uncontrolled hypertension, or smoking over age 35), as these patients were appropriately using progestin-only DMPA but cannot safely use Seasonale. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

3-month contraceptive injection approved.

FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration, 1993

Research

Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 1998

Guideline

Risks of Long-Term Depo Provera Use Beyond 2 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Depo Provera Administration and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Provera (Medroxyprogesterone Acetate) Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.